Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm of the opinion the PPS is going to increase above that intersection point in the next 5-10 trading days. All IMO
NP
'Golden Cross' Coming
The golden cross is a bullish breakout pattern formed from a crossover involving a security's short-term moving average (such as the 15-day moving average) breaking above its long-term moving average (such as 50-day moving average) or resistance level. As long-term indicators carry more weight, the golden cross indicates a bull market on the horizon and is reinforced by high trading volumes.
Golden Cross Definition | Investopedia http://www.investopedia.com/terms/g/goldencross.asp#ixzz4D5fLEjbu
All IMO
NP
Because some like to insinuate dilution at slow times like this, I thought I'd check the status of the PTX Authorized Shares. Maryland still has the A/S at 140 million common/10 million preferred. Nothing has been filed to increase that number since it was established last July.
http://sdat.dat.maryland.gov/ucc-charter/Pages/CharterSearch/default.aspx
Just an FYI.
Nupapa
Buying the fear. Thanks UK for today's AA gift.
20-day MA and 50-day MA keep tightening. Good sign.
Nupapa
Some perspective on sales --
Found this in an April 2016 article:
http://smartinvestor.business-standard.com/market/story-378184-storydet-NPPA_caps_prices_of_70_new_drugs.htm#.V2KsZsecHNU
Zolpidem, which is used to cure insomnia and certain brain disorders, now has a ceiling price of Rs 8 per tablet. Abbott controls 70 per cent of this drug's market. Zolpidem has annual sales of Rs 42 crore in India.
Crore is a unit in Indian numerical system which is equivalent to 10 million. So 42 Crore would be 420 million -- that's about $623,000 in sales within India alone -- and PTX just said Silenor is better.
Good news long term.
NP
Have to think it helps Treximet sales
You are referring to is this, right?
On May 9, 2016, Pernix Therapeutics Holdings, Inc. (the "Company") notified the Nasdaq Stock Market ("Nasdaq") that John Sedor, a director of the Company, was appointed Interim Chief Executive Officer of the Company and that Mr. Sedor resigned from each of the Company's Audit Committee and Compensation Committee. As a result, the Company is not currently in compliance with the "three independent member audit committee" requirement of Nasdaq Listing Rule 5605(c)(2)(A) and intends to rely on the cure period provision of Nasdaq Listing Rule 5605(c)(4)(B). This cure period will run through November 5, 2016. If the Company does not regain compliance by such date, Nasdaq rules require the Nasdaq Staff to provide written notice to the Company that its securities will be delisted and, at that time, the Company may appeal the delisting determination. The Company intends to appoint an additional independent director to its Board and each of its committees, including the Audit Committee, prior to the end of the cure period provided by the Nasdaq rules noted above.
I think she's referring to the share price being below $1. I've seen nothing (other than the minor audit team issue above) about delisting due to failure to comply with NASDAQ PPS rules. https://listingcenter.nasdaq.com/home.aspx
NP
This is the last agenda I've seen:
1. to elect four directors for a term of one year;
2. to approve, on an advisory basis, our executive compensation as disclosed in the attached proxy statement (“say-on-pay”);
3. to ratify the selection of Cherry Bekaert L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
4. to consider a stockholder proposal concerning majority voting in uncontested elections of directors of the Company, if properly presented at the meeting; and
5. to transact such other business as may properly come before the meeting or any postponement or adjournment thereof.
Get Proxy Details Here:
https://www.iproxydirect.com/PTX
The 2016 Annual Meeting of Stockholders to be held at the Hyatt Morristown at Headquarters Plaza, 3 Speedwell Avenue, Morristown, New Jersey 07960, on May 26, 2016 at 10:00 a.m., local time.
The 2016 Annual Meeting of Stockholders to be held at the Hyatt Morristown at Headquarters Plaza, 3 Speedwell Avenue, Morristown, New Jersey 07960, on May 26, 2016 at 10:00 a.m., local time.
On July 21, 2015, we raised 1.6 million dollars through a private placement. Using the proceeds of this offering, we resumed ginseng beverage production in October 2015, and produced a new reduced size ginseng beverage (40 ML) in January 2016.
We believe that we will be able to continue to improve our sales of ginseng juice in 2016 through 1) an online shopping platform that we have been developing since October 2015 and which will provide customers with easy and convenient access to our products; 2) rebuilding our distribution network; and 3) starting to establish our own nationwide network of stores to sell ginseng beverage. However, assuming those changes occur, there is no assurance that our sales of ginseng beverage will meet our expectation as the market conditions may change.
Meanwhile, in order to enhance overall revenue of the Company to generate profits, we are going to establish a new business, which is a network of eye health care centers under our subsidiary Jilin Huaxia in May, 2016 and we expect that we will generate the revenue from this business in 2016. However, there is no assurance that such sales will meet our expectation as the market conditions may change.
I'm glad they found another consultant/advisor to pay. I was getting worried
8K TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.
http://www.sec.gov/Archives/edgar/data/1503161/000100201415000303/libe8k-06172015.htm
On June 17, 2015, Union Capital Funding, exercised its final conversion under that certain convertible promissory note dated July 17, 2014 in the original principal amount of $25,000.00 with interest thereon at the rate of 12% until paid which conversion constituted payment in full of the outstanding balance on said convertible promissory note.
On June 17, 2015, GEL Properties LLC, exercised its final conversion under that certain convertible promissory note dated December 2, 2014 in the original principal amount of $35,000.00 with interest thereon at the rate of 12% until paid which conversion constituted payment in full of the outstanding balance on said convertible promissory note.
On June 17, 2015, JMJ Financial, exercised its final conversion under that certain convertible promissory note dated September 9, 2013 in the original principal amount of $25,000.00 with interest thereon at the rate of 12% until paid which conversion constituted payment in full of the outstanding balance on said convertible promissory note.
I don't think you can right now because of the chill. Some folks have been able to buy because they don't live in the U.S.
Waiting on final SS of new company and lifting of the chill. Then it's go time.
There's a DTCC Chill on SSPT until My Big Coin clears it up. It'll get taken care of and has nothing to do with the company going forward.
You're welcome
In the words of Dave Hester - Storage Wars. YUUUUUUPPP!!!
Is this about right?
http://investor.abm.com/images/ABM_Infographic.jpg
Closed up today at $33 and Noted the Electrical Solutions number of 40,000 on the top left.
In reference to this statement?
Over the past 4 weeks I've been speaking to a $32 per share company that manages over 40,000 parking lot lights here in the US alone.
Here's the address I used:
Kristian Schiorring <gekssc@gmail.com>
Nupapa
Sorry no. I've been traveling the last four weeks and haven't had the time to reach out.
Somebody is nervous about the buying.
Nice find. HEMP definitely likes the Guard Lite from LIBE
Nupapa
He's been gone way too long for his name even to be brought up. But you knew that right?
I only posted because it came to my in box. I hold no shares anymore after years of holding. If I was holding I'd be checking the Share Structure over the next couple days. We've seen them line their pockets before. I don't trust management anymore. If someone else stepped in and cleaned house I might feel differently.
GLTA holding here.
Nupapa
I don't share your optimism but I wish you the best of luck.
Nupapa
Letter to Shareholders (April 20, 2015):
http://mhtx.com/assets/media/pdf/Letter_to_Shareholders.pdf
To our Shareholders
Manhattan Scientifics, Inc. owns and is commercializing two nanotechnology businesses: nanostructured metals through our Metallicum subsidiary, and nanotechnology for the very early detection of cancers through our Senior Scientific subsidiary.
The past year has been an important one for Manhattan Scientifics with a number of notable achievements. On the nano metals side of our enterprise, we concluded an arrangement with our former industrial partner for the successful return of the licensing rights, intellectual property including all patent rights, nanotechnology manufacturing machinery, plus $8M cash - a total exceeding $18 million of new assets. As a result, our company has never been stronger financially. We are now able to accelerate activities in both our Senior Scientific and our Metallicum subsidiaries with minimal near term dilution.
The Road to Profit and Shareholder Value
OUR LICENSING BUSINESS MODEL: We want to remind you, our shareholders, that we follow a licensing business model. Our goal is to increase the value of your MHTX shares through the conclusion of collaborative license partnerships with the larger pharma and/or medical device equipment manufacturers. While it may take years before we see mass distribution of MRX instruments into the marketplace, our management is seeking to generate value though the conclusion of licensing partnerships enabling "the majors" to use and further enhance our technology and patents.
Achievements
Our Senior Scientific subsidiary met many of its goals including the deployment of our first MRX cancer detection instrument at the MD Anderson Cancer Center (MDA) and the acceleration and expansion of our collaboration with MDA. This collaboration resulted in MDA’s publication of a science poster at the World Molecular Imaging Conference that described our MRX technology as “unparalleled in terms of sensitivity compared to imaging-based ovarian cancer detection methods; thus, it holds promise for detecting ovarian cancer much earlier than otherwise possible."
We continue our successful collaboration with the Center for Integrated Nanotechnologies (CINT) at Sandia and Los Alamos National Laboratories, where we have advanced our nanotechnology capability. This collaboration has also served CINT well and they have publicized our cancer break-through in a multi- year exhibit featuring Senior Scientific and the work of its founder physicist, Edward R. Flynn, PhD at the Bradbury Science Museum in Los Alamos, NM, the 6th most important Science Museum in the USA.
Recently, we have expanded our relationship with the Los Alamos National Laboratory (LANL) to work with us on an advanced sensor design. One of the world’s foremost authorities on low field magnetic sensors from LANL is now working directly for us at Senior Scientific to produce the next generation of cancer detection instruments.
We have internally demonstrated that our nanoparticle (N-P) technology provides better reliable quality and more consistent controlled size than ever before possible; important to many applications including our very early detection of cancer technology.
??Moreover, we are nearing completion of our own in-house N-P production facility, which will give us a complete razor (magnetic instruments) and razor blade (nanoparticles) business opportunity. We intend to license our proprietary know-how and patents to major industrial partners and simultaneously provide the medical community with injectable nanoparticles for use with our MRX diagnostic instruments.
We recruited Bob Proulx, our new president/COO, to lead Senior Scientific. Bob is a veteran business executive with more than 25 years of leadership experience with both private and public companies in the life science and diagnostic device markets. Most recently, he served as Chief Commercial Officer and General Manager of U.S. Operations for Silicon Biosystems, Inc., whose image-based cell sorting technology is advancing personalized medicine initiatives in cancer through the molecular characterization of tumor heterogeneity.
Gerald Grafe, former president of Senior Scientific, remains with our company focusing on intellectual property and patenting as our IP portfolio continues to grow.
In another important move, Marvin Maslow agreed to return as Chairman of the Board further reflecting the confidence and dedication Marv has for Manhattan Scientifics.
Outlook:
Senior Scientific Our basic science of magnetic relaxometry and nanoparticle technology in the company is sound and represents low technical risk. However, there is still work needed to commercialize our science and bring product to the market, which will ultimately lead to creation of substantial shareholder value for you, the owners of our Company.
Our continuing collaboration with the MD Anderson Cancer Center, Houston, demonstrating the effective use of the MRX technology in a hospital setting speaks volumes about our technology and about MDA's enthusiasm for our work. Our goal is to expand this collaborative relationship and leverage MDA’s medical expertise to address early identification of multiple types of cancers. We are moving forward promptly on this front.
We plan to diversify and reach out to other important cancer research hospitals. Success at M.D. Anderson Cancer Center is expected to trigger significant interest across the spectrum of global cancer research hospitals. Our technology is a diagnostic that can be paired with many different therapies. We are in contact with other companies who have developed important cancer therapeutic technologies. We are exploring potential joint venturing with such companies.
Metallicum Since re-acquiring the nano-metals technology from our former licensed industrial partner in February 2015, we are moving forward on two fronts.
We are setting up a low cost R&D facility near the Colorado School of Mines to enhance our business opportunities and to provide sample materials for prospective customers.
We have retained the services of Imperial Capital, LLC. www.imperialcapital.com to help us identify major partner(s) to move the technology forward under license and/or potential sales agreements to bring product to the market. Kevin Frisch, who is heading that effort, is Imperial Capital’s M&A specialist in the metals sector. He and his M&A team are highly confident in their ability to create value for us.
We also are exploring and working with potential customers in the fields of titanium dental implants, titanium and magnesium, cardio vascular stents, high voltage aluminum electrical transmission conductors, and several oil and gas exploration applications.
??We have the intellect, the intellectual capital, the cash, the energy, the support of our brilliant team of scientists and engineers, the support of the M.D. Anderson Cancer Center and the American Cancer Society on our side. We believe all the pieces are in place to create value for you, our shareholders. All of us at Manhattan Scientifics and its subsidiaries look forward to updating you of our accomplishments throughout the remainder of this year. THANK YOU for your continued support and confidence in our work.
Manny Tsoupanarias President & CEO
Tata Industries (India) - I think he's got you beat on shares. LOL
http://www.sec.gov/cgi-bin/own-disp?action=getowner&CIK=0001066630
Nupapa
Ugly and annoying.
If an insider is buying at $13.14 I'm comfortable that we're in at a good price.
http://www.sec.gov/Archives/edgar/data/4281/000000428115000040/xslF345X03/edgar.xml
Nupapa
If AA isn't $50 plus in a few years I'll be stunned. Too many market trends in their favor. The repositioning of the company has been outstanding imo.
GLTY.
Np
I can't pass up buys at these prices. Added today and now holding 2,000 shares long term. Everything about AA seems right to me. I'm not a squirrel chasing every squirrel in the park.
Nupapa
GMA - LIBE longs will be rewarded. Everything else is just noise IMO.
Happy Trading!!!
Nupapa
If you market products in national publications you have products being manufactured. I don't care one bit how folks react to this news. If they don't see long-term value they aren't looking.
All IMO
Nupapa
Good catch on 7th distributor
Nice Cramer Breakdown on AA:
http://finance.yahoo.com/news/cramer-big-money-flow-stock-222654327.html
Nupapa